Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnoCore does not have its own therapeutic pipeline but has supported over twenty product development projects using its proprietary controlled-release technologies. The company’s SynBiosys® platform enables long-term injectable formulations for small molecules and biologics. It has been recognized by major partners such as Allergan in ophthalmology and MilliporeSigma globally. Clinical results pertain to partner/client products utilizing their platforms rather than internal assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InnoCore Pharmaceuticals.